ethyl 4-(3,5-dimethoxyphenyl)-4-oxobutyrate, 97.0%, 2g

2-((2R,3R)-3-(tert-butyl)-4-methoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 95%,99%ee, 500mg

(R)-3-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid, 97%, 5g

2-(3,4-DIMETHOXYPHENYL)-2-METHYLPROPANENITRILE, 97.0%, 1g

(R)-1-(2,4-Difluorophenyl)ethanamine hydrochloride, 95.0%, 5g

2,2-Dimethylbenzo[d][1,3]dioxole, 95.0%, 10g

1-Bromo-3,5-difluorobenzene, 98.0%, 250g

2-Methylbenzo[e]indene (mixture of 1H- and 3H-form)>97.0%(GC)100mg

2'-Methyl-3'-nitroacetanilide>98.0%(GC)5g

4-Bromo-N-methylphthalimide>98.0%(GC)5g

1,5-Dimethyl-1H-pyrazole-4-carboxylic acid, 97.0%, 10g

7-Bromo-N-(1,3-dimethylpyrazol-4-yl)quinazolin-2-amine, 98%, 250mg

2-(Pyrrolidin-1-yl)thiazole, 95.0%, 10g